Noninvasive ventilation: a decade of progress Elliott M., Ambrosino N. Eur Respir J 2002; 19: 587-589 | |
A European framework for effective tuberculosis control Davies P.D.O. Eur Respir J 2002; 19: 590-592 | |
Mortality in asthmatics over 15 yrs: a dynamic cohort study from 1983-1998 Connolly C.K., Alcock S.M., Prescott R.J. Eur Respir J 2002; 19: 593-598 | |
Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study Eagan T.M.L., Bakke P.S., Eide G.E., Gulsvik A. Eur Respir J 2002; 19: 599-605 | |
Effect of inhaled heparin on lung function and coagulation in healthy volunteers Bendstrup K.E., Gram J., Jensen J.I. Eur Respir J 2002; 19: 606-610 | |
Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine Ketchell R.I., Jensen M.W., Spina D., O'Connor B.J. Eur Respir J 2002; 19: 611-616 | |
Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease Gosker H.R., van Mameren H., van Dijk P.J., Engelen M.P.K.J., van der Vusse G.J., Wouters E.F.M., Schols A.M.W.J. Eur Respir J 2002; 19: 617-625 | |
Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD Steiner M.C., Barton R.L., Singh S.J., Morgan M.D.L. Eur Respir J 2002; 19: 626-631 | |
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Santos S., Peinado V.I., Ramirez J., Melgosa T., Roca J., Rodriguez-Roisin R., Barbera J.A. Eur Respir J 2002; 19: 632-638 | |
Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease van Noord J.A., Smeets J.J., Custers F.L.J., Korducki L., Cornelissen P.J.G. Eur Respir J 2002; 19: 639-644 | |
Is waking electroencephalographic activity a predictor of daytime sleepiness in sleep-related breathing disorders? Sforza E., Grandin S., Jouny C., Rochat T., Ibanez V. Eur Respir J 2002; 19: 645-652 | |
Determinants of Fi,O2 with oxygen supplementation during noninvasive two-level positive pressure ventilation Thys F., Liistro G., Dozin O., Marion E., Rodenstein D.O. Eur Respir J 2002; 19: 653-657 | |
Nocturnal periodic breathing in primary pulmonary hypertension Schulz R., Baseler G., Ghofrani H.A., Grimminger F., Olschewski H., Seeger W. Eur Respir J 2002; 19: 658-663 | |
Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders Ghofrani H.A., Wiedemann R., Rose F., Weissmann N., Schermuly R.T., Quanz K., Grimminger F., Seeger W., Olschewski H. Eur Respir J 2002; 19: 664-671 | |
Human alveolar epithelial cells induce nitric oxide synthase-2 expression in alveolar macrophages Pechkovsky D.V., Zissel G., Stamme C., Goldmann T., Ari Jaffe H., Einhaus M., Taube C., Magnussen H., Schlaak M., Muller-Quernheim J. Eur Respir J 2002; 19: 672-683 | |
Prostaglandin D2 inhibits fibroblast migration Kohyama T., Liu X.D., Wen F.Q., Kim H.J., Takizawa H., Rennard S.I. Eur Respir J 2002; 19: 684-689 | |
Traffic-related air pollution and respiratory health during the first 2 yrs of life Gehring U., Cyrys J., Sedlmeir G., Brunekreef B., Bellander T., Fischer P., Bauer C.P., Reinhardt D., Wichmann H.E., Heinrich J. Eur Respir J 2002; 19: 690-698 | |
The effect of air pollution on inner-city children with asthma Mortimer K.M., Neas L.M., Dockery D.W., Redline S., Tager I.B. Eur Respir J 2002; 19: 699-705 | |
Induced sputum: time from expectoration to processing Efthimiadis A., Jayaram L., Weston S., Carruthers S., Hargreave F.E. Eur Respir J 2002; 19: 706-708 | |
The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Oguzulgen I.K., Ekim N.N., Akar N., Demirel K., Kitapci M. Eur Respir J 2002; 19: 709-711 | |
Noninvasive ventilation for acute respiratory failure Brochard L., Mancebo J., Elliott M.W. Eur Respir J 2002; 19: 712-721 | |
Diagnostic imaging of lung cancer Hollings N., Shaw P. Eur Respir J 2002; 19: 722-742 | |
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Reichenberger F., Habicht J.M., Gratwohl A., Tamm M. Eur Respir J 2001 Jan 01;19(4):743-755 | |
Sulphasalazine and lung toxicity Parry S.D., Barbatzas C., Peel E.T., Barton J.R. Eur Respir J 2002; 19: 756-764 | |
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Broekmans J.F., Migliori G.B., Rieder H.L., Lees J., Ruutu P., Loddenkemper R., Raviglione M.C. Eur Respir J 2002; 19: 765-775 | |
Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS Tegtmeyer F.K., Moller J., Zabel P. Eur Respir J 2002; 19: 776-779 | |
Dyspnoea and cyanosis in a cirrhotic patient Stratakos G., Malagari K., Broutzos E., Zakynthinos E., Roussos C., Papiris S. Eur Respir J 2002; 19: 780-783 | |
Management of oesophageal carcinoma with associated lung tuberculosis Kotsis L., Poczi M., Orban K. Eur Respir J 2002; 19: 784-785 | |
Lung mucosal immunity: immunoglobulin-A revisited Lusuardi M., Capelli A., Di Stefano A., Donner C.F. Eur Respir J 2002; 19: 785-786 | |